Viewing Study NCT06354764



Ignite Creation Date: 2024-05-06 @ 8:21 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06354764
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-11
First Post: 2024-04-03

Brief Title: Propensity to Hospitalize Patients From the ED in European Centers
Sponsor: Mario Negri Institute for Pharmacological Research
Organization: Mario Negri Institute for Pharmacological Research

Study Overview

Official Title: Propensity to Hospitalize Patients From the ED in European CentersAn Observational Retrospective Quality-of-care Study
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: eCREAM-UC1
Brief Summary: The peer-to-peer comparison means center-to-center comparison which requires adjusting for possible differences among centers to be fair and convincing The first step to reach this goal is to develop a predictive model that accurately estimates each patients probability of being admitted starting from clinical conditions and boundary variables Such a model would make it possible to calculate for each ED the expected hospitalization rate that is the hospitalization rate that would have been observed if the ED had behaved like the average of the EDs that provided the data to build the model itself Comparing the observed hospitalization rate in the single ED with the expected rate derived from the model provides a rigorous method of comparing the department with the average performance taking into account the characteristics of the patients treated and the conditions under which the ED operated In other words the predictive model represents the benchmark against which each ED is evaluated
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None